Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
If all other chronic diseases are treated with multiple drugs, why not type 1 diabetes? Other challenges in accessing adjunctive therapies Insurance coverage Most people with type 1 have a challenging time getting insurance coverage for adjunctive therapies, though some are able to come up with creative workarounds
Glucagon raises blood sugar, so activating that receptor sounds counterproductive for diabetes
Reach out if anythings wrong
Always consult a healthcare professional before considering any research compound
US$ 21.61
US$ 29.77
US$ 26.44
